New hope for Tough-to-Treat ovarian cancer

NCT ID NCT04908787

Summary

This study tested whether adding an experimental drug called BD0801 to standard chemotherapy works better than chemotherapy alone for women with recurrent ovarian cancer that has stopped responding to platinum-based drugs. It involved 421 women whose cancer returned within 6 months of prior platinum therapy. The goal was to see if the combination could better control the cancer's growth and spread.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Affiliated Hospital of Jining Medical University

    Jining, Shandong, China

  • Affiliated Hospital of North Sichuan Medical College

    Nanchong, Sichuan, China

  • Beijing Obstetrics and Gynecology Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Cancer Hospital Chinese Academy Of Medical Sciences, Shenzhen Center

    Shenzhen, Guangdong, China

  • Cancer Hospital Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China

  • Cancer Hospital of Shantou University Medical College

    Shantou, Guangdong, China

  • Chongqing Cancer Hospital

    Chongqing, Chongqing Municipality, China

  • Fujian Provincial Cancer Hospital

    Fuzhou, Fujian, China

  • Fukuang General Hospital of Liaoning Health Industry Group

    Fushun, Liaoning, China

  • Guangxi Medical University Cancer Hospital&Guangxi Cancer Institute, Guangxi Cancer Hospital&Medical University School&Cancer Center

    Nanning, Guangxi, China

  • Guizhou Provincial People's Hospital

    Guiyang, Guizhou, China

  • Hainan General Hospital

    Haikou, Hainan, China

  • Hangzhou Cancer Hospital

    Hangzhou, Zhejiang, China

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, China

  • Hubei Cancer Hospital

    Wuhan, Hubei, China

  • Hunan Cancer Hospital

    Changsha, Hunan, China

  • Jiangsu Cancer Hospital

    Nanjing, Jiangsu, China

  • Jiangxi Maternal and Child Health Hospital

    Nanchang, Jiangxi, China

  • Jilin Cancer Hospital

    Changchun, Jilin, China

  • Liaoning Cancer Hospital & Institute

    Shenyang, Liaoning, China

  • Linyi Cancer Hospital

    Linyi, Shandong, China

  • Mianyang Central Hospital

    Mianyang, Sichuan, China

  • Nanjing Women and Children's Healthcare Hospital, Women's Hospital of Nanjing Medical University

    Nanjing, Jiangsu, China

  • Nantong Cancer Hospital

    Nantong, Jiangsu, China

  • Obstetrics & Gynecology Hospital of Fudan University

    Shanghai, Shanghai Municipality, China

  • Peking University First Hospital

    Beijing, Beijing Municipality, China

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China

  • Second Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China

  • Shandong Cancer Hospital & Institute

    Jinan, Shandong, China

  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, China

  • The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital

    Zhengzhou, Henan, China

  • The First Affiliated Hospital of Bengbu Medical University

    Bengbu, Anhui, China

  • The First Affiliated Hospital of USTC West District,Anhui Provincial Cancer Hospital

    Hefei, Anhui, China

  • The First Affiliated Hospital of University of South China

    Hengyang, Hunan, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • The First Hospital of Jilin University

    Changchun, Jilin, China

  • The Fourth Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • The Second Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • The Second Hospital of Anhui Medical University

    Hefei, Anhui, China

  • The Second Hospital of Dalian Medical University

    Dalian, Liaoning, China

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • The Second Norman Bethune Hospital of Jilin University

    Changchun, Jilin, China

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • Tianjin Center Hospital of Gynecology Obstetrics

    Tianjin, Tianjin Municipality, China

  • Tianjin Medical University Cancer Institute & Hospital

    Tianjin, Tianjin Municipality, China

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • Xuzhou Central Hospital(Southeast University Affiliated Hospital)

    Xuzhou, Jiangsu, China

  • Yantai Yuhuangding Hospital

    Yantai, Shandong, China

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, China

  • Zhejiang Provincial People's Hospital

    Hangzhou, Zhejiang, China

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, China

Conditions

Explore the condition pages connected to this study.